Is Medical Device Tax a Lame Duck?

Source: Mass Device (10/12/12)

"There's a growing confidence among medical device industry insiders that there may be an opportunity to repeal the medical device tax in the interim session between the November election and the seating of a new Congress—no matter who wins the race to the White House."

There's a growing confidence among medical device industry insiders that there may be an opportunity to repeal the medical device tax in the interim session between the November election and the seating of a new Congress—no matter who wins the race to the White House.

"I believe there is an opportunity to repeal [the medical device tax] during the lame duck session," Mark Leahey, CEO of the Medical Device Manufacturing Assn., said during the OCTANe Medical Device Investors Forum in Irvine, Calif this week. "I'm confident we could get a repeal."

Leahey said his organization, which represents small and mid-sized medical device manufacturers, has had several fruitful conversations with Democratic senators, who he believes will support a repeal efforts if a bill is brought up for a vote on the Senate floor. . .View Full Article

Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (01/28/2021)

Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.

Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports (01/15/2021)

Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.

Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues
Source: Streetwise Reports (01/13/2021)

Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%.

Biotech Collaborates to Advance Psychedelics Use in Cancer, Other Applications
Source: Streetwise Reports (11/23/2020)

Revive Therapeutics enters an agreement with PharmaTher, a specialty psychedelics pharmaceutical firm.

Glaukos Shares Pressured Higher After Firm Reports 11% Rise in Q3 Revenue
Source: Streetwise Reports (11/06/2020)

Shares of Glaukos Corp. traded 9% higher after the company reported Q3/20 financial results that included an 11% YoY increase in glaucoma and corneal health net sales.

Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports (11/03/2020)

Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue.

Shares of Align Technology traded 35% higher and climbed to a new 52-week high after the company reported Q3/20 financial results that included a 20.9% YoY increase in net revenues.

U.S. Medical Device Firm to Acquire Developer of Dissection Stent
Source: Streetwise Reports (09/09/2020)

The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg Thalmann report.

AI Tech Firm Provides COVID-19 Contact Tracing Solution Update
Source: Streetwise Reports (07/20/2020)

Loop Insights continues to educate governments and venue operators around the world about its easily implemented platform.

Announcing Streetwise Live! Events
Source: Streetwise Reports (07/13/2020)

Streetwise Reports is offering 100 investors—at no charge—the opportunity to meet via Zoom with executives of precious metals companies as they discuss recent developments at their companies and upcoming catalysts.